rel-N-メチル-N-[(5R*)-7α*-(1-ピロリジニル)-1-オキサスピロ[4.5]デカン-8β*-イル]ベンゼンアセトアミド

rel-N-メチル-N-[(5R*)-7α*-(1-ピロリジニル)-1-オキサスピロ[4.5]デカン-8β*-イル]ベンゼンアセトアミド 化学構造式
96744-75-1
CAS番号.
96744-75-1
化学名:
rel-N-メチル-N-[(5R*)-7α*-(1-ピロリジニル)-1-オキサスピロ[4.5]デカン-8β*-イル]ベンゼンアセトアミド
别名:
rel-N-メチル-N-[(5R*)-7α*-(1-ピロリジニル)-1-オキサスピロ[4.5]デカン-8β*-イル]ベンゼンアセトアミド;U-69593
英語名:
U-69593
英語别名:
U-69593;U-69593 SELECTIVE K OPIOID AG;U-69593, kappa1-opioid receptor agonist;N-Methyl-N-(7-(1-pyrrolidinyl)-1-oxaspiro(4,5)dec-8-yl)benzeneacetamide;N-Methyl-N-[(5R,7S,8S)-7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]benzeneacetamide;Benzeneacetamide, N-methyl-N-((5R,7S,8S)-7-(1-pyrrolidinyl)-1-oxaspiro(4.5)dec-8-yl)-;(5A,7A,8B)-(-)-N-METHYL-(7-(1-PYRROLIDINYL)-1-OXASPIRO (4.5)DEC-8- YL)BENZENEACETAMIDE);U69593, (+)-(5α,7α,8β)-N-Methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]-benzeneacetamide;(5ALPHA,7ALPHA,8BETA)-(+)-N-METHYL-N-(7-[1-PYRROLIDINYL]-1-OXASPIRO[4.5]DEC-8-YL)-BENZENEACETAMIDE;(+)-(5ALPHA,7ALPHA,8BETA)-N-METHYL-N-[7-(1-PYRROLIDINYL)-1-OXASPIRO[4.5]DEC-8-YL]-BENZENEACETAMIDE
CBNumber:
CB0432261
化学式:
C22H32N2O2
分子量:
356.5
MOL File:
96744-75-1.mol
MSDS File:
SDS

rel-N-メチル-N-[(5R*)-7α*-(1-ピロリジニル)-1-オキサスピロ[4.5]デカン-8β*-イル]ベンゼンアセトアミド 物理性質

融点 :
120-123℃
沸点 :
518.7±50.0 °C(Predicted)
比重(密度) :
1.13
RTECS 番号:
CY1490060
貯蔵温度 :
2-8°C
溶解性:
H2O: 14 mg/mL
外見 :
個体
酸解離定数(Pka):
9.15±0.20(Predicted)
色:
白い
光学活性 (optical activity):
[α]/D +7.8°, c = 0.825 in methanol(lit.)
水溶解度 :
45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: 10mg/mL
0.1 M HCl: >40mg/mL
ethanol: >40mg/mL
0.1 M NaOH: insoluble
H2O: insoluble

安全性情報

WGK Germany  3

rel-N-メチル-N-[(5R*)-7α*-(1-ピロリジニル)-1-オキサスピロ[4.5]デカン-8β*-イル]ベンゼンアセトアミド 化学特性,用途語,生産方法

使用

U-69593 is a selective κ-opioid receptor agonist. A safe opioid analgesic.

定義

ChEBI: U69593 is a monocarboxylic acid amide obtained by formal condensation between the carboxy group of phenylacetic acid and the secodary amino group of (5R,7S,8S)-N-methyl-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]decan-8-amine. It has a role as a kappa-opioid receptor agonist, an anti-inflammatory agent and a diuretic. It is an oxaspiro compound, a N-alkylpyrrolidine, an organic heterobicyclic compound and a monocarboxylic acid amide.

生物学の機能

U-69593 is a single enantiomer with very high selectivity for the kappa receptor in vitro (mu/kappa ratio = 484). It was radiolabelled by a catalytic exchange of tritium for the two aromatic chlorine substituents of the precursor. This ligand is commercially available and has been widely used as a radiolabel for the kappa receptor.
in spinal cordslice preparations from the 9-16-day-old rat,U-69593 produced a na-loxone-reversible depression of spontaneous and electrically evoked activityin dorsal horn neurones.

Biochem/physiol Actions

U-69593 is a selective κ opioid receptor agonist. U-69593 is known to inhibit cocaine sensitization in meso-limbic dopamine neurons by normalizing basal overflow of dopamine.

rel-N-メチル-N-[(5R*)-7α*-(1-ピロリジニル)-1-オキサスピロ[4.5]デカン-8β*-イル]ベンゼンアセトアミド 上流と下流の製品情報

原材料

準備製品

96744-75-1(rel-N-メチル-N-[(5R*)-7α*-(1-ピロリジニル)-1-オキサスピロ[4.5]デカン-8β*-イル]ベンゼンアセトアミド)キーワード:


  • 96744-75-1
  • U-69593
  • (+)-(5ALPHA,7ALPHA,8BETA)-N-METHYL-N-[7-(1-PYRROLIDINYL)-1-OXASPIRO[4.5]DEC-8-YL]-BENZENEACETAMIDE
  • (5ALPHA,7ALPHA,8BETA)-(+)-N-METHYL-N-(7-[1-PYRROLIDINYL]-1-OXASPIRO[4.5]DEC-8-YL)-BENZENEACETAMIDE
  • U-69593 SELECTIVE K OPIOID AG
  • (5A,7A,8B)-(-)-N-METHYL-(7-(1-PYRROLIDINYL)-1-OXASPIRO (4.5)DEC-8- YL)BENZENEACETAMIDE)
  • Benzeneacetamide, N-methyl-N-((5R,7S,8S)-7-(1-pyrrolidinyl)-1-oxaspiro(4.5)dec-8-yl)-
  • Benzeneacetamide, N-methyl-N-(7-(1-pyrrolidinyl)-1-oxaspiro(4.5)dec-8-yl)-, (5alpha,7alpha,8beta)-(-)-
  • N-Methyl-N-(7-(1-pyrrolidinyl)-1-oxaspiro(4,5)dec-8-yl)benzeneacetamide
  • N-Methyl-N-[(5R,7S,8S)-7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]benzeneacetamide
  • U69593, (+)-(5α,7α,8β)-N-Methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]-benzeneacetamide
  • U-69593, kappa1-opioid receptor agonist
  • rel-N-メチル-N-[(5R*)-7α*-(1-ピロリジニル)-1-オキサスピロ[4.5]デカン-8β*-イル]ベンゼンアセトアミド
  • U-69593
  • 利尿薬
  • 麻薬性鎮痛薬
Copyright 2017 © ChemicalBook. All rights reserved